David T Ting

Title: David T Ting: Innovator in Cancer Treatment Technologies

Introduction

David T Ting is a prominent inventor based in Dover, MA (US), known for his significant contributions to cancer treatment technologies. With a total of 8 patents, he has developed innovative methods and devices aimed at improving patient outcomes in oncology.

Latest Patents

Among his latest patents is the invention titled "Targeting Human Satellite II (HSATII)," which focuses on methods for treating cancer, particularly cancers of epithelial origin. This patent involves the use of sequence-specific agents, such as oligonucleotides, to specifically target HSATII. Another notable patent is for "Local Drug Delivery Devices and Methods for Treating Cancer." This invention describes drug-eluting devices designed for the treatment of tumors located in the pancreas, biliary system, gallbladder, liver, small bowel, or colon. The methods include deploying a drug-eluting device that contains a film made from a mixture of a degradable polymer and a chemotherapeutic drug. The film's thickness ranges from about 2 µm to about 1000 µm, allowing for controlled release of the drug at the tissue site through in vivo degradation of the polymer.

Career Highlights

David T Ting has worked with esteemed organizations such as The General Hospital Corporation and the Massachusetts Institute of Technology. His work in these institutions has significantly advanced the field of cancer treatment, showcasing his dedication to medical innovation.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Shyamala Maheswaran and Daniel Arie Haber. These partnerships have contributed to the development of groundbreaking technologies in cancer treatment.

Conclusion

David T Ting's innovative work in cancer treatment technologies has made a lasting impact on the field of oncology. His patents reflect a commitment to improving therapeutic methods and patient care.